The Chicago Prostate Cancer Center has been chosen by the American Brachytherapy Society to be the first site to offer a 3 month brachytherapy fellowship. Chicago Prostate Cancer Center was strategically selected as the first due to our extensive experience in the prostate cancer and brachytherapy fields.
“We are thrilled to host the first 3 month brachytherapy fellowship at Chicago Prostate Cancer Center. I look forward to supporting American Brachytherapy Society’s mission by training the next generation of LDR brachytherapists”, said Dr. Brian J. Moran, Medical Director of Chicago Prostate Cancer Center.
We continue to invest in offering not only the best possible treatments to patients but also continued research and advancements in the fight against this disease.
Overall Brachytherapy Fellowship Initiative
The CPCC prostate brachytherapy fellowship is part of a broader initiative by the American Brachytherapy Society called 300 in 10. The goal of this initiative is to provide comprehensive training to 30 qualified brachytherapists per year over the next 10 years. This will be achieved through a multi-faceted approach to include raising public awareness, working to change Accreditation Council for Graduate Medical Education (ACGME) brachytherapy requirements, fostering advances in training to include simulation, developing brachytherapy curricula for residents, and establishing centers of excellence to augment and improve on current brachytherapy training to include 3-month brachytherapy fellowship opportunities.
CPCC Brachytherapy Medical Fellowship Details
We’re offering one resident a prostate 3-month fellowship starting next month, which is generously co-sponsored by Theragenics Corporation. The resident will have hands-on experience and will become a proficient LDR brachytherapist upon completion. By the end of the brachytherapy fellowship, the participant will be able to:
- Identify clinical appropriateness (low, intermediate, high-risk patients
- Learn and utilize the latest techniques
- Realize the roles of each team member in the treatment process
- Detail the risk and management of post implant complications
- Explain the concept and importance of radiation safety
- Participate in further research opportunities
About the American Brachytherapy Society
Founded in 1978, the American Brachytherapy Society (ABS) is a nonprofit organization that seeks to provide insight and research into the use of brachytherapy in malignant and benign conditions. The organization consists of approximately 1,500 physicists, physicians, and other health care providers interested in brachytherapy.
About Chicago Prostate Cancer Center
Founded in 1997, Chicago Prostate Cancer Center has been providing guidance and treatment for over 20,000 men affected by prostate cancer over the last 20 years. CPCC is led by Dr. Brian Moran, who specializes in the diagnosis and treatment of prostate cancer. They offer evidence-based recommendations from the most current research data, which assures patients that they have the most up-to-date information possible. Dr. Brian has spoken at national conferences, published articles in numerous medical journals and proctored other physicians on brachytherapy both in the U.S. and internationally.